GENERAL21 Sept 2026
Drugs regulator plans curbs on doctors dispensing medicines | Mint
India's drug regulator may tighten Schedule K, which lets registered medical practitioners dispense medicines straight to their own patients without a retail drug licence. There is no cap on how much stock they can hold, so officials fear misuse. New rules could set a maximum stock limit and push routine supplies back to pharmacies. If you run a clinic, start tracking dispensing quantities and pharmacy purchases.
Key Statutory Highlights
- Schedule K under the Drugs Rules, 1945 allows registered medical practitioners (RMPs) to supply and dispense prescription medicines directly to their own patients without a retail drug licence, as long as they do not run an open shop.
- The current rules set no ceiling on the quantity of medicines an RMP can stock for dispensing, which officials say creates an enforcement grey area and a possible loophole for misuse.
- A similar proposal was approved by the 56th Drugs Consultative Committee in June 2019 but was rejected by the Drugs Technical Advisory Board in August 2019, as it was seen as interfering with doctors' clinical autonomy.
Actionable Advice for Taxpayers / Founders:If you are a doctor who dispenses medicines, keep a simple record of the stock you hold and dispense to your own patients, and watch for the draft amendment. This is only a proposal right now, so no new stock limit applies to you yet.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: